Home Healthcare Pharmaceuticals Anti-VEGF Therapeutics Market

Anti-VEGF Therapeutics Market Size, Share & Trends Analysis Report By Product (Eylea, Lucentis, Beovu, Vabysmo, Others), By Disease Type (Macular Edema, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular Degeneration, Myopic Choroidal Neovascularization) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 05, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
  7. North America Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  8. Europe Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    6. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  9. APAC Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    7. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  10. Middle East and Africa Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  11. LATAM Anti-VEGF Therapeutics Market Size Analysis
    1. Introduction
    2. Anti-VEGF Therapeutics Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Eylea
      2. Lucentis
      3. Beovu
      4. Vabysmo
      5. Others
    3. Anti-VEGF Therapeutics Market Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
      1. Macular Edema
      2. Diabetic Retinopathy
      3. Retinal Vein Occlusion
      4. Age-related Macular Degeneration
      5. Myopic Choroidal Neovascularization
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Eylea
        2. Lucentis
        3. Beovu
        4. Vabysmo
        5. Others
      3. Market Size & Forecast By Disease Type 2022-2034 (USD MILLION/ Units)
        1. Macular Edema
        2. Diabetic Retinopathy
        3. Retinal Vein Occlusion
        4. Age-related Macular Degeneration
        5. Myopic Choroidal Neovascularization
  12. Competitive Landscape
    1. Anti-VEGF Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Regeneron Pharmaceuticals, Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Bayer AG
    3. Novartis AG
    4. Hoffmann-La Roche Ltd.
    5. Frensius Kabi
    6. Biogen
    7. Pfizer, Inc.
    8. Alvotech
    9. Teva Pharmaceuticals
    10. Coherus Biosciences, Inc.
    11. Amgen, Inc.
    12. Bausch Health Companies, Inc.
    13. Viatris, Inc.
    14. Sanofi
    15. Isarna Therapeutics
    16. Genentech
    17. SamChunDang Pharm
    18. Roche
    19. Formycon AG
    20. Bioeq AG
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.